301
Participants
Start Date
June 30, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Placebo
Tablets (n=4), 0 mg twice daily for 84 days
25 mg PF-04991532
Tablets (n=1), 25 mg strength + tablets (n=3) 0 mg twice daily for 84 days
75 mg PF-04991532
Tablets (n=3), 25 mg strength + tablets (n=1) 0 mg twice daily for 84 days
150 mg PF-04991532
Tablets (n=1), 150 mg strength + tablets (n=3) 0 mg twice daily for 84 days
300 mg PF-04991532
Tablets (n=2), 150 mg strength + tablets (n=2) 0 mg twice daily for 84 days
Sitagliptin 100 mg
Tablets (n=1), 100 mg strength + tablets (n=3) 0 mg once daily in the morning for 84 days; and tablets (n=4) 0 mg once daily in the evening for 84 days.
Pfizer Investigational Site, Taoyuan
Pfizer Investigational Site, Kistelek
Pfizer Investigational Site, Balatonfüred
Pfizer Investigational Site, Lansdale
Pfizer Investigational Site, Aguascalientes
Pfizer Investigational Site, Richmond
Pfizer Investigational Site, Norfolk
Pfizer Investigational Site, Charlotte
Pfizer Investigational Site, Coral Gables
Pfizer Investigational Site, Ocala
Pfizer Investigational Site, Lexington
Pfizer Investigational Site, Taichung
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Indianapolis
Pfizer Investigational Site, Tlalnepantla
Pfizer Investigational Site, Brooklyn Center
Pfizer Investigational Site, Fargo
Pfizer Investigational Site, Overland Park
Pfizer Investigational Site, Augusta
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Lake Charles
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Katy
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Denver
Pfizer Investigational Site, Las Vegas
Pfizer Investigational Site, Roseville
Pfizer Investigational Site, Honolulu
Pfizer Investigational Site, Auburn
Pfizer Investigational Site, Trenton
Pfizer Investigational Site, Surrey
Pfizer Investigational Site, Bay Roberts
Pfizer Investigational Site, Brampton
Pfizer Investigational Site, Mississauga
Pfizer Investigational Site, Mirabel
Pfizer Investigational Site, Québec
Pfizer Investigational Site, Mexico City
Pfizer Investigational Site, Bratislava
Pfizer Investigational Site, Nové Mesto nad Váhom
Pfizer Investigational Site, Pezinok
Pfizer Investigational Site, Prešov
Lead Sponsor
Pfizer
INDUSTRY